CBT Advisors is a consultancy founded in 2003 working with private biotechnology, life sciences and medical device companies on storytelling and strategy. We are based in Cambridge, MA. Much of the firm’s work focuses on drafting business sections for NASDAQ IPOs. As of October, 2020, fifty-nine clients have gone public, raising $5.9 billion. Recent IPO clients have included Zentalis, Repare, Black Diamond, Pliant Therapeutics, iTeos, Legend Biotech and Allovir. Earlier clients included CRISPR Therapeutics, Karuna Therapeutics, Alector, Translate Bio, ArgenX, Personalis, Inspire Medical, Vapotherm and others.
Looking for a particular CBT Advisors employee's phone or email?
The CBT Advisors annual revenue was $192000 in 2026.
Steven Dickman is the Founder and CEO of CBT Advisors.
2 people are employed at CBT Advisors.
CBT Advisors is based in Cambridge, Massachusetts.
The NAICS codes for CBT Advisors are [541, 54171, 541713, 54, 5417].
The SIC codes for CBT Advisors are [87, 873].